Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood–CSF barrier dysfunction

Abstract

Immune and inflammatory mechanisms are detected in a subgroup of treatment resistant hospitalized affective and schizophrenic spectrum disorder patients. We analysed albumin, IgG, IgA, IgM, oligoclonal IgG and specific antibodies in paired cerebrospinal fluid (CSF) and serum samples. Numerical and graphical interpretation of CSF protein data was performed by Reibergrams with a new CSF statistics tool for nonlinear group analysis with reference to a large control group (n = 4100). In 41% of the psychiatric patients (n = 63) we observed CSF pathologies: 14% displayed intrathecal humoral immune responses, 10% slightly increased CSF cell counts (5–8/μL) and 29% had moderate blood–CSF barrier dysfunctions, in 24% as the only pathological sign with normal IgG, IgA and IgM concentrations in CSF (p = 0.9 testing the null hypothesis for intrathecal synthesis with reference to Qmean of the reference group). In the group of affective (n = 24) spectrum disorders 20% displayed a systemic immune reaction as detected by oligoclonal IgG. CSF analysis and interdisciplinary clinical approach revealed 6% of psychiatric patients likely to represent a virusspecific, bacterial or autoimmune associated disorder with CNS involvement. Elevated CSF neopterin concentration in 34% of the patients was interpreted as an increased release from astrocytes or from other glia cells. The low level immune response and barrier dysfunctions are discussed on the base of a mild encephalitis pathomechanism in subgroups of psychiatric patients. CSF analysis is shown to be a useful diagnostic tool for differential diagnosis in psychiatric diseases.

Introduction

Epidemiological, clinical and post mortem studies indicate that inflammatory and immune reactions are involved in the pathomechanisms of affective and schizophrenic spectrum disorders (Davis et al., 2003, Sperner-Unterweger, 2005, Irwin and Miller, 2007, Yolken and Torrey, 2008). Cytokine abnormalities were reported since long (Licinio and Wong, 1999). Infections are suggested to increase the risk of psychiatric disorders at various time points (during pregnancy, around delivery or later during childhood) and apparently by different pathogenetic mechanisms (Yolken and Torrey, 2008, Meyer et al., 2008, Buka et al., 2008, Dalman et al., 2008, Bechter and Bogerts, 2007). The increased frequency of autoimmune disorders in psychosis pedigrees (Eaton et al., 2006) adds another piece to the puzzle, the scenario matching with pathogenesis in autoimmune disorders. In general this requires three factors (Rioux and Abbas, 2005): genes, environment and immune system. Yet first treatment approaches were successfully applied in spectrum psychoses, e.g., add-on therapy with Cox-2 blockers (Müller et al., 2002, Müller et al., 2006), antiviral add-on treatment (Dickerson et al., 2003), immune modulatory treatment (Bechter et al., 2000) or neuroprotective treatment (Ehrenreich et al., 2007). Immune suppressive treatment was proposed (Knight et al., 2007).

Nevertheless, hypotheses to explain psychotic disorders vary: neurodevelopmental alteration induced by immune inflammatory mediators or infectious agents (Meyer et al., 2008), a specific role of macrophages in depression (Smith, 1992), cytokine abnormalities and inflammation interacting with neurodegeneration (Myint and Kim, 2003, Leonard, 2007), imbalance of Th1 and Th2 type immunity and related glutamate abnormalities (Müller and Schwarz, 2007) or mild encephalitis (ME) underlying a subgroup of psychiatric spectrum disorders (Bechter, 2001). Pathogenetic hypotheses may in parallel or alternatively fit the individual case, therefore reliable diagnostic tools are needed.

Cerebrospinal fluid (CSF) investigation represents the most sensitive and specific approach to detect and characterize CNS inflammation (Wildemann et al., 2006). Evaluation of paired CSF and blood samples is regarded as the gold standard (Sindic et al., 2001, Reiber and Peter, 2001). In neurology, the knowledge based interpretation of disease-related CSF data patterns allows an important contribution of CSF analysis to differential diagnosis. In psychiatric disorders CSF investigation is recommended only for the purpose to exclude meningoencephalitis and plays a minor role in psychiatric diagnosis and research.

In this study we investigated psychiatric inpatients of the schizophrenic and affective spectrum for blood–CSF barrier (BCB) function, the humoral and cellular intrathecal immune response and interpreted the humoral immune response using Reibergrams (Reiber and Peter, 2001) supported by a newly developed statistic approach for evaluation of CSF protein data in patient groups (Reiber and Albaum, 2008). Together with the intrathecal antibody synthesis directed against defined antigens and intrathecal auto-antibodies production we made a first approach to support the assumed low level immune responses (Bechter, 2001) and to explain moderate blood–CSF barrier dysfunctions. We investigated also neopterin production and tryptophan–kynurenine pathway involved in various infectious and autoimmune disorders (Dotevall et al., 1990, Heyes et al., 1992, Hagberg et al., 1993). Neopterin production and tryptophan degradation are closely linked to Th1-type immune activation and measurements of these metabolic changes should therefore allow some insight into the potential role of immune activation in patients with schizophrenic and affective spectrum disorders.